In case anyone missed this presentation.
https://www.aats.org/resources/lb4-prospective-single-center-randomized-control-trial-to-evaluate-the-safety-and-feasibility-of-a-novel-allogenic-mesenchymal-precursor-cell-therapy-in-patients-with-hypoplastic-left-heart-syndrome-2
Doctors are impatient for this stem cell therapy for their patients… not my words but
rather the words from a doctor during question time.
Well done to Boston’s Children’s Hospital for trailblazing this new treatment… again a doctor’s words, not mine.
Bring on MSB’s Phase 3 trial
In case anyone missed this presentation....
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.005(0.42%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.14 | $10.05M | 8.604M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 8510 | 1 |
View Market Depth
| Last trade - 15.59pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.18 |
Change
-0.005 ( 0.31 %) |
||||
| Open | High | Low | Volume | ||
| $1.18 | $1.20 | $1.14 | 1465927 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| MSB (ASX) Chart |